Opposite spectrum of activity of canonical wnt signaling in the osteogenic context of undifferentiated and differentiated mesenchymal cells: Implications for tissue engineering

Tissue Engineering - Part A

Volumn 16, Issue 10, 2010, Pages 3185-3197

  Quarto, Natalina ^a,b   Behr, Björn ^a,c   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; BIOACTIVITY; BONE; CYTOLOGY; DEFECTS; SIGNALING; STEM CELLS; TISSUE ENGINEERING; TRANSCRIPTION FACTORS;

ADIPOSE DERIVED STEM CELLS; ADULT MICE; BIOLOGICAL ACTIVITIES; BONE DEFECT; BONE REGENERATION; BONY TISSUE; CALVARIAL DEFECTS; CANONICAL WNT SIGNALING; DOMINANT NEGATIVE; DOSE-DEPENDENT; DOSE-DEPENDENT MANNER; EXPRESSION LEVELS; HIGH DOSE; IN-VITRO; IN-VIVO; LOW DOSE; MESENCHYMAL CELLS; OSTEOGENESIS; OSTEOGENIC; OSTEOGENIC DIFFERENTIATION; THRESHOLD LEVELS; TISSUE REGENERATION;

OSTEOBLASTS;

MUS;

WNT PROTEIN; WNT3 PROTEIN;

ANIMAL; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; MESENCHYMAL STEM CELL; METABOLISM; METHODOLOGY; MOUSE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; MESENCHYMAL STEM CELLS; MICE; OSTEOGENESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; WNT PROTEINS;

EID: 77957666829     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0133     Document Type: Article

References (49)

1. Gimble, J.M., Katz, A.J., and Bunnell, B.A. Adipose-derived stem cells for regenerative medicine. Circ Res 100, 1249, 2007.
2. Zuk, P.A., Zhu, M., Ashjian, P., De Ugarte, D.A., Huang, J.I., Mizuno, H., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13, 4279, 2002.
3. Izadpanah, R., Trygg, C., Patel, B., Kriedt, C., Dufour, J., Gimble, J.M., et al. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem 99, 1285, 2006.
4. Baksh, D., Song, L., and Tuan, R.S. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8, 301, 2004.
5. Quarto, N., Wan D.C., and Longaker, M.T. Molecular Mechanisms of FGF-2 inhibitory activity in the osteogenic context of mouse adipose-derived stem cells (mASCs). Bone 42, 1040, 2008.
6. Gimble, J.M., and Guilak, F. Differentiation potential of adipose derived adult stem (ADAS) cells. Curr Top Dev Biol 58, 137, 2003.
7. Lee, J.A., Parrett, B.M., Conejero, J.A., Laser, J., Chen, J., Kogon, A.J., et al. Biological alchemy: engineering bone and fat from fat-derived stem cells. Ann Plast Surg 50, 610, 2003.
8. Cowan, C.M., Shi, Y.Y., Aalami, O.O., Chou, Y.F., Mari, C., Thomas, R., et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 22, 560, 2004.
9. Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7, 211, 2001.
10. Karsenty, G. Minireview: transcriptional control of osteo-blast differentiation. Endocrinology 142, 2731, 2001.
11. Karsenty, G. Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet 9, 183, 2008.
12. Karsenty, G., Wagner, E.F. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2, 389, 2002.
13. Karsenty, G., Kronenberg, H.M., and Settembre, C. Genetic control of bone formation. Annu Rev Cell Dev Biol 25, 629, 2009.
14. Ash, P., Loutit, J.F., and Townsend, K.M. Osteoclasts derived from haematopoietic stem cells. Nature 283, 669, 1980.
15. Suda, T., Takahashi, N., and Martin, T.J. Modulation of os-teoclast differentiation. Endocr Rev 13, 66, 1992.
16. Matushansky, I., Hernando, E., Socci, N.D., Mills, J.E., Matos, T.A., Edgar, M.A., et al. Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. J Clin Invest 117, 3248, 2007.
17. Nannuru, K.C., and Singh, R.K. Tumor-stromal interactions in bone metastasis. Curr Osteoporos Rep 8, 105, 2010.
18. Clevers, H. Wnt/beta-catenin signaling in development and disease. Cell 127, 469, 2006.
19. Kurihara, N., Zhou, H., Reddy, S.V., Garcia Palacios, V., Subler, M.A., Dempster, D.W., et al. Experimental models of Paget's disease. J Bone Miner Res 21 Suppl 2, P55, 2006.
20. Marie, P.J. Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 316, 23, 2003.
21. Logan, C.Y., and Nusse, R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20, 781, 2004.
22. Chen, Y., and Alman, B.A. Wnt pathway, an essential role in bone regeneration. J Cell Biochem 106, 353, 2009.
23. Reya, T., and Clevers, H. Wnt signalling in stem cells and cancer. Nature 434, 843, 2005.
24. Hill, T.P., Spater, D., Taketo, M.M., Birchmeier, W., and Hartmann, C. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 8, 727, 2005.
25. Chen, Y., Whetstone, H.C., Lin, A.C., Nadesan, P., Wei, Q., Poon, R., et al. Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLoS Med 4, e249, 2007.
26. Chung, B.D., Kayserili, H., Ai, M., Freudenberg, J., Uzumcu, A., Uyguner, O., et al. A mutation in the signal sequence of LRP5 in a family with an osteoporosis-pseudoglioma syndrome (OPPG)-like phenotype indicates a novel disease mechanism for trinucleotide repeats. Hum Mutat 30, 641, 2009.
27. Hartmann, C. A Wnt canon orchestrating osteoblastogen-esis. Trends Cell Biol 16, 151, 2006.
28. Galceran, J., Farinas, I., Depew, M.J., Clevers, H., and Grosschedl, R. Wnt3a-/\like phenotype and limb deficiency in Lef1(-/-)Tcf1(-/-) mice. Genes Dev 13, 709, 1999.
29. Glass, D.A., 2nd, Bialek, P., Ahn, J.D., Starbuck, M., Patel, M.S., Clevers, H., et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8, 751, 2005.
30. Gong, Y., Slee, R.B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A.M., et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107, 513, 2001.
31. Day, T.F., Guo, X., Garrett-Beal, L., and Yang, Y. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8, 739, 2005.
32. Gaur, T., Lengner, C.J., Hovhannisyan, H., Bhat, R.A., Bod-ine, P.V., Komm, B.S., et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280, 33132, 2005.
33. Krishnan, V., Bryant, H.U., and Macdougald, O.A. Regulation of bone mass by Wnt signaling. J Clin Invest 116, 1202, 2006.
34. Little, R.D., Carulli, J.P., Del Mastro, R.G., Dupuis, J., Osborne, M., Folz, C., et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70, 11, 2002.
35. Macsai, C.E., Foster, B.K., and Xian, C.J. Roles of Wnt signalling in bone growth, remodelling, skeletal disorders and fracture repair. J Cell Physiol 215, 578, 2008.
36. Quarto, N., and Longaker, M.T. FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng 12, 1405, 2006.
37. Quarto, N., Wan, D.C., Kwan, M.D., Panetta, N.J., Li, S., and Longaker, M.T. Origin matters: differences in embryonic tissue origin and Wnt signaling determine the osteogenic potential and healing capacity of frontal and parietal cal-varial bones. J Bone Miner Res 2009 [Epub ahead of print].
38. Kolligs, F.T., Hu, G., Dang, C.V., and Fearon, E.R. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol Cell Biol 19, 5696, 1999.
39. Quarto, N., Finger, F.P., and Rifkin, D.B. The NH2-terminal extension of high molecular weight bFGF is a nuclear targeting signal. J Cell Physiol 147, 311, 1991.
40. Quarto, N., and Longaker, M.T. Differential expression of specific FGF ligands and receptor isoforms during osteo-genic differentiation of mouse adipose-derived stem cells (mASCs) recapitulates the in vivo osteogenic pattern. Gene 424, 130, 2008.
41. Liu, G., Vijayakumar, S., Grumolato, L., Arroyave, R., Qiao, H., Akiri, G., et al. Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells. J Cell Biol 185, 67, 2009.
42. Boland, G.M., Perkins, G., Hall, D.J., and Tuan, R.S. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Bio-chem 93, 1210, 2004.
43. de Boer, J., Siddappa, R., Gaspar, C., van Apeldoorn, A., Fodde, R., and van Blitterswijk, C. Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone 34, 818, 2004.
44. Cho, H.H., Kim, Y.J., Kim, S.J., Kim, J.H., Bae, Y.C., Ba, B., et al. Endogenous Wnt signaling promotes proliferation and suppresses osteogenic differentiation in human adipose derived stromal cells. Tissue Eng 12, 111, 2006.
45. Kawano, Y., and Kypta, R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116, 2627, 2003.
46. Semenov, M., Tamai, K., and He, X. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem 280, 26770, 2005.
47. Semenov, M.V., Tamai, K., Brott, B.K., Kuhl, M., Sokol, S., and He, X. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 11, 951, 2001.
48. Winkler, D.G., Sutherland, M.K., Geoghegan, J.C., Yu, C., Hayes, T., Skonier, J.E., et al. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 22, 6267, 2003.
49. Quarto, N., Behr, B., Li, S., and Longaker, M.T. Differential FGF ligands and FGF receptors expression pattern in frontal and parietal calvarial bones. Cells Tissues Organs 190, 158, 2009.